PRESCRIBING · PART D · 2024
Total Rx claims
297
Beneficiaries
—
Total drug cost
$1.6M
Distinct drugs
13
Brand share
52.2%
Top prescribed drugs
Immun Glob G(Igg)/Gly/Iga Ov5051 claims
Diazepam48 claims
Baclofen30 claims
Gabapentin24 claims
Omaveloxolone23 claims
QUALITY · MIPS · 2024
Final MIPS score
94.5
Quality
80.6
Cost
0.0
Improvement activities
40.0
Promoting interop.
100.0
Payment adjustment
0.82%
APM Entity
INDUSTRY PAYMENTS · OPEN PAYMENTS · 2025
No data available for this provider in 2025.
FACILITY AFFILIATIONS
Hospital & Facility Affiliations (3)
REFERRAL NETWORK
Where George Wilmot's patients come from & go
Directional shared-patient flow from Medicare claims — who sends patients to this provider (inbound) and where this provider's patients go next (outbound). 1 inbound referrers · 3 outbound destinations.
Receives referrals from
Inbound — who sends patients here
| Physician | Patients | Visits |
|---|---|---|
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 11 | 16 |
Refers patients to
Outbound — where patients go next
| Physician | Patients | Visits |
|---|---|---|
| EMORY UNIVERSITY | 41 | 209 |
| John Roback Pathology · Atlanta, GA | 31 | 181 |
| Laboratory Corporation Of America Holdings Clinical Laboratory · Birmingham, AL | 11 | 34 |
Source: CMS Physician Shared Patient Patterns (30-day window, Medicare FFS). Direction = a beneficiary seen by the first provider, then the second, within 30 days; a proxy for referral, not a documented referral. Pairs with fewer than 11 shared beneficiaries are suppressed.
CROSS-REFERENCE